65
video
Supercharge the Search for Cures: Medical Philanthropists Reinvent Giving to Get Results
The Milken Institute's Center for Strategic Philanthropy and its predecessor, the Philanthropy Adv
isory Service, have conducted more than a dozen deep dives into "disease philanthropy." These inquiries have yielded valuable lessons on how philanthropist
+ Read More
video
Young Entrepreneurs Who Are Rewriting the Biopharma Business Model
Even as scientific progress accelerates, the industry that turns those advances into medical treat
ments is relying on decades-old business strategies.
+ Read More
video
Joe Biden: Get the right therapy the first time
Joe Biden shares his goals and progress with the Cancer Breakthroughs 2020 project.
video
A Conversation with Scott Gottlieb, Commissioner, U.S. Food and Drug Administration
This closing session will begin with a conversation with Scott Gottlieb, Commissioner, U.S. Food a
nd Drug Administration, moderated by FasterCures' Tanisha Carino.
+ Read More
video
Finding a Cure for the Cost of Durable Therapies
"Curative" is not a word that we can use very often in medicine, especially when talking about dis
eases such as cancer and rare genetic disorders. However, the first curative therapies are already here, and the wave is coming.
+ Read More
article
Milken Institute statement on ARPA-H inclusion in FY2022 spending bill
Esther Krofah
Executive Director
Milken Institute FasterCures and Center for Public Health
article
We Need a Medical Revolution in the United States
The damage has been done. Hundreds of thousands of Americans perished and the pandemic took a $16 tr
illion toll on the US economy., This is a time to think more boldly than ever, and it should inspire our leaders to demand real change.
, We were led to believe the answer to the question of how long it takes from initial research to advanced drug development: 10 years. This has been repeated—and accepted—for decades.
+ Read More
article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically
Dr. Robert Califf
Commissioner
US Food and Drug Administration
Silver Spri
ng, MD 20993
Dear Dr. Califf,
+ Read More
article
Medicare Drug Price Negotiation Program comment letter
Submitted electronically
Dr. Meena Seshamani
Deputy Administrator and Director, Center for Medicare
Centers for Medicare & Medicaid Services
US Department of Health and Human Services
Baltimore, MD 21244
+ Read More